Defibrotide Prophylaxis of Transplant Associated-Thrombotic Microangiopathy for Neuroblastoma

NCT06182410 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Industry sponsor decision

Conditions

Transplant-Associated Thrombotic Microangiopathy
Neuroblastoma
High-risk Neuroblastoma
Thrombotic Microangiopathies

Interventions

DRUG: Defibrotide

Sponsor

University of California, San Francisco

Collaborators

[object Object]